Phase II Study of GW786034 in Patients With Relapsed or Refractory Soft Tissue Sarcoma.
Phase of Trial: Phase II
Latest Information Update: 01 Jan 2017
At a glance
- Drugs Pazopanib (Primary)
- Indications Soft tissue sarcoma
- Focus Therapeutic Use
- Sponsors GlaxoSmithKline
- 11 Oct 2016 Results of a retrospective analysis from EORTC6204, EORTC62072 studies and additional clinical data from real life setting investigating the activity of pazopanib in vascular sarcomas, presented at the 41st European Society for Medical Oncology Congress
- 12 Mar 2016 Pooled analysis of 2 studies (n=44), including this study and other trial (see CTP 700037621) were published in the Gynecologic Oncology.
- 19 Nov 2012 Planned End Date changed from 1 May 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.